Recently, it was shown that PSEN1 hypomethylation led to increased gene expression in the blood of AD patients as well as post-mortem AD brain regions, implying that it might be an epigenetic biomarker for the disease [227]. Here, PSEN1 is linked to Alzheimer disease.